ReviewFrontiers in bioengineering and biotechnology2025

SLC26A9 in triple-negative breast cancer stem cells: a network pharmacology and molecular modeling study.

Mimi Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.